Analysis of N-nitroso-nebivolol, Nitroso Drug Substance Related impurity in Nebivolol 20 mg tablet formulation using LC-MS/MS system

Postery | 2025 | Agilent Technologies | ASMSInstrumentace
LC/MS, LC/MS/MS, LC/QQQ
Zaměření
Farmaceutická analýza
Výrobce
Agilent Technologies
PDF verze ke stažení a čtení
 

Podobná PDF

Quantitation of N-Nitroso Nebivolol in Nebivolol Tablet Formulation
Quantitation of N-Nitroso Hydrochlorothiazide in Losartan- Hydrochlorothiazide Tablets
Quantitation of N-Nitroso Moxifloxacin in 400 mg Moxifloxacin Tablet Formulation
Determination of Genotoxic Nitrosamine Impurity in Bumetanide API and Tablets Using the Agilent 6470 Triple Quadrupole LC/MS